it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people. . . .
your reason has been reported to the admin.